Hamamatsu Photonics is happy to announce an enlargement of the supposed use of the NanoZoomer MD sequence in Europe to incorporate cytology slide digitization. The expanded medical software scope helps laboratories looking for higher consistency, effectivity, and diagnostic confidence in mobile picture analysis.

Picture Credit score: Hamamatsu Photonics Europe
Enhanced digital capabilities for cytology The expanded supposed use is supported by findings from the lately revealed research Validation of Digital Cytology for Major Prognosis Throughout a Vary of Specimen Sorts, carried out by researchers at College School London and College School London Hospitals NHS Basis Belief and revealed in Cytopathology. With the expanded supposed use, the NanoZoomer MD sequence in Europe can now be used to amass digital photos from a broad vary of cytology preparations, together with:
- Typical Pap smears
- Liquid-based cytology samples
- Non-gynecological preparations
- High-quality-needle aspirates (FNAs)
Cytology analysis depends upon superb element recognition, nuclear options, and refined chromatic variations. The NanoZoomer MD sequence in Europe helps these wants by way of:
- Excessive-resolution optical seize for correct visualization
- Constant coloration replica to help reproducible assessments
- Automated focus and scanning stability
The result’s a dependable digital setting that helps pathologists in delivering high-quality medical evaluations.
Enabling Laboratories in Their Digital Transformation
By incorporating cytology into its supposed use, the NanoZoomer MD sequence in Europe offers pathology establishments the flexibility to:
- Consolidate histology and cytology on a single digital platform
- Speed up case assessment and distant collaboration
- Help long-term digital archiving methods
Dedication to Pathology Excellence
This enlargement displays Hamamatsu’s ongoing dedication to enabling totally digital workflows throughout the spectrum of pathology, together with each histology and cytology, and aligns with rising medical demand for high-quality digital photos for routine assessment, session, and archiving.
“We’re proud to broaden the supposed use of the NanoZoomer MD Collection,” mentioned Martin Kristensson, Strategic Advertising Supervisor at Hamamatsu Photonics Europe. “Cytology has been a key request from our medical companions, and this enlargement reinforces Hamamatsu’s long-standing dedication to offering excessive precision, clinically validated imaging options that meet the evolving wants of contemporary pathology.”
References
T. Mistry, H. Hunter, D. Oukrif, S. Pomplun, R. Patel, M. Rodriguez-Justo, and A. P. Levine, “Validation of digital cytology for major prognosis throughout a variety of specimen sorts,” Cytopathology, Mar. 10, 2026. [Online]. Out there: doi:10.1111/cyt.70063.
Supply:
